Partial Laryngectomy for pT4a Laryngeal Cancer: Outcomes and Limits in Selected Cases

Author:

Succo Giovanni12ORCID,Bertolin Andy3,Santos Izabela Costa4,Tascone Martina1,Lionello Marco3,Fantini Marco1,de Freitas Andressa Silva4,Bertotto Ilaria5,Sprio Andrea Elio6ORCID,Sanguineti Giuseppe7,Dias Fernando Luiz4,Rizzotto Giuseppe3,Crosetti Erika1

Affiliation:

1. Otorhinolaryngology Unit, San Giovanni Bosco Hospital, 10154 Turin, Italy

2. Oncology Department, University of Turin, 10124 Torino, Italy

3. Otorhinolaryngology Unit, Vittorio Veneto Hospital, AULSS2 Treviso, 31029 Vittorio Veneto, Italy

4. Brazilian National Cancer Institute, Rio de Janeiro 20230-130, RJ, Brazil

5. Radiology Service, Candiolo Cancer Institute FPO IRCCS, Candiolo, 10060 Turin, Italy

6. Department of Research, ASOMI College of Sciences, 2080 Marsa, Malta

7. Department of Radiation Oncology, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy

Abstract

A large multi-institutional case series of laryngeal cancer (LC) T4a was carried out, including 134 cases treated with open partial horizontal laryngectomies (OPHL) +/− post-operative radiation therapy (PORT). The goal was to understand better whether OPHL can be included among the viable options in selected pT4a LC patients who refuse a standard approach, represented by total laryngectomy (TL) + PORT. All 134 patients underwent OPHL type I (supraglottic), II (supracricoid), or III (supratracheal), according to the European Laryngological Society Classification. Comparing clinical and pathological stages showed pT up-staging in 105 cases (78.4%) and pN up-staging in 19 patients (11.4%). Five-year data on overall survival, disease-specific survival, disease-free survival, freedom from laryngectomy, and laryngo-esophageal dysfunction-free survival (rate of patients surviving without a local recurrence or requiring total laryngectomy and without a feeding tube or a tracheostomy) were, respectively, 82.1%, 89.8%, 75.7%, 89.7%, and 78.3%. Overall, complications were observed in 22 cases (16.4%). Sequelae were observed in 28 patients (20.9%). No patients died during the postoperative period. This large series highlights the good onco-functional results of low-volume pT4a laryngeal tumors, with minimal or absent cartilage destruction, treated with OPHLs. The level of standardization of the indication for OPHL should allow consideration of OPHL as a valid therapeutic option in cases where the patient refuses total laryngectomy or non-surgical protocols with concomitant chemo-radiotherapy.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference34 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J. Clin.,2007

2. Allegra, E., Bianco, M.R., Ralli, M., Greco, A., Angeletti, D., and de Vincentiis, M. (2021). Role of Clinical-Demographic Data in Survival Rates of Advanced Laryngeal Cancer. Medicina, 57.

3. Influential factors, complications and survival rate of primary and salvage total laryngectomy for advanced laryngeal cancer;Stojanov;Coll. Antropol.,2012

4. Larynx preservation clinical trial design: Summary of key recommendations of a consensus panel;Ang;Oncologist,2010

5. AIOM (2022, January 01). Linee Guida Tumori Delle Testa e Del Collo. Edizione. Available online: https://www.aiom.it/wp-content/uploads/2018/11/2018_LG_AIOM_TestaCollo.pdf.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3